SARS-CoV-2 controlled human infection models: Ethics, challenge agent production and regulatory issues
Marc Baay, Pieter Neels
Abstract
This second International Alliance for Biological Standardization COVID-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable participation from low- and middle-income countries, to discuss the use of controlled human infection models to accelerate development and market authorization assessment of a vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Topics & Concepts
StandardizationAuthorizationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)AllianceProduction (economics)2019-20 coronavirus outbreakBusinessCoronavirusVirologyMedicinePolitical scienceEconomicsLawComputer securityPathologyComputer scienceOutbreakInfectious disease (medical specialty)MacroeconomicsDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesCOVID-19 Clinical Research Studies